BioCentury Emerging Company Profile: Artios: Probing DNA Damage

Artios is attacking a different DNA Damage Response pathway that could be more selective than PARP inhibitors.

https://www.biocentury.com/biocentury/emerging-company-profile/2019-01-11/how-artios-attacking-different-dna-damage-response-

View all news